Protease-activated receptors: potential therapeutic targets in irritable bowel syndrome?

Author： Gloro Romain   Ducrotte Philippe   Reimund Jean-Marie  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.9, Iss.5, 2005-10, pp. : 1079-1095

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protease-Activated Receptors as Therapeutic Targets in Visceral Pain

By  

Current Neuropharmacology, Vol. 11, Iss. 6, 2013-12 ,pp. : 598-605

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of protease-activated receptor-1 antagonists

By Derian Claudia K   Maryanoff Bruce E   Zhang Han-Cheng   Andrade-Gordon Patricia  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 209-221

Informa Healthcare

Access to resources Recommend Favorite

CRF1 Receptors as a Therapeutic Target for Irritable Bowel Syndrome

By  

Current Pharmaceutical Design, Vol. 12, Iss. 31, 2006-01 ,pp. : 4071-4088

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Protease-Activated Receptors for the Development of Myocarditis: Possible Therapeutic Implications

By  

Current Pharmaceutical Design, Vol. 22, Iss. 4, 2016-02 ,pp. : 472-484

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Targeting Protease Activated Receptors in Cardiovascular Diseases

By  

Current Pharmaceutical Design, Vol. 21, Iss. 30, 2015-10 ,pp. : 4392-4399

Bentham Science Publishers

Access to resources Recommend Favorite